Evaluation of co-morbid conditions among refractory or unexplained chronic cough patients in two phase 2 randomized controlled trials

Chronic Cough ◽

Controlled Trials ◽

Phase 2 ◽

Two Phase ◽

Randomized Controlled ◽

Morbid Conditions

Rationale and design of two, phase 3, randomized controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory and unexplained chronic cough

World Allergy Organization Journal ◽

10.1016/j.waojou.2020.100203 ◽

2020 ◽

Vol 13 (8) ◽

pp. 100203

Author(s):

David Muccino ◽

George Philip ◽

A.H. Morice ◽

S.S. Birring ◽

L. Mcgarvey ◽

...

Keyword(s):

Receptor Antagonist ◽

Chronic Cough ◽

Controlled Trials ◽

P2x3 Receptor ◽

Phase 3 ◽

Two Phase ◽

Rationale and Design of Two, Phase 3, Randomized Controlled Trials (COUGH-1 and COUGH-2) of Gefapixant, A P2x3 Receptor Antagonist, in Refractory and Unexplained Chronic Cough

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4700 ◽

2019 ◽

Author(s):

D. Muccino ◽

A.H. Morice ◽

S.S. Birring ◽

L. McGarvey ◽

P. Dicpinigaitis ◽

...

Keyword(s):

Receptor Antagonist ◽

Chronic Cough ◽

Controlled Trials ◽

P2x3 Receptor ◽

Phase 3 ◽

Two Phase ◽

Dose Selection for Two, Phase 3, Randomized Controlled Trials (Cough-1 and Cough-2) in Refractory or Unexplained Chronic Cough

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a7649 ◽

2020 ◽

Author(s):

A. Hussain ◽

C. La Rosa ◽

A. Tershakovec ◽

H. Jan Kleijn ◽

D. Muccino

Keyword(s):

Chronic Cough ◽

Controlled Trials ◽

Dose Selection ◽

Phase 3 ◽

Two Phase ◽

Randomized Controlled ◽

Selection For

Incidence of cardiac toxicities in patients with advanced non-small cell lung cancer treated with osimertinib: A combined analysis of two phase III randomized controlled trials

Annals of Oncology ◽

10.1093/annonc/mdy292.011 ◽

2018 ◽

Vol 29 ◽

pp. viii500 ◽

Cited By ~ 1

Author(s):

K.Z. Thein ◽

S. Swarup ◽

S. Ball ◽

M. Quirch ◽

Y. Vorakunthada ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Controlled Trials ◽

Small Cell Lung ◽

Two Phase ◽

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials

Psychopharmacology ◽

10.1007/s00213-019-05249-5 ◽

2019 ◽

Vol 236 (9) ◽

pp. 2735-2745 ◽

Cited By ~ 40

Author(s):

Michael C. Mithoefer ◽

Allison A. Feduccia ◽

Lisa Jerome ◽

Anne Mithoefer ◽

Mark Wagner ◽

...

Keyword(s):

Study Design ◽

Pooled Analysis ◽

Controlled Trials ◽

Phase 2 ◽

Phase 3 ◽

767 Efficacy and Safety of Oral Tofacitinib As Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis: Results From Two Phase 3 Randomized Controlled Trials

Gastroenterology ◽

10.1016/s0016-5085(16)30622-9 ◽

2016 ◽

Vol 150 (4) ◽

pp. S157 ◽

Cited By ~ 7

Author(s):

William Sandborn ◽

Bruce E. Sands ◽

Geert R. D'Haens ◽

Severine Vermeire ◽

Stefan Schreiber ◽

...

Keyword(s):

Ulcerative Colitis ◽

Induction Therapy ◽

Controlled Trials ◽

Efficacy And Safety ◽

Phase 3 ◽

Two Phase ◽

Severe Ulcerative Colitis ◽

Abstract P4-16-06: Incidence of interstitial lung disease in patients with HER2-positive advanced breast cancer treated with everolimus and trastuzumab: A combined analysis of two phase 3 randomized controlled trials

10.1158/1538-7445.sabcs18-p4-16-06 ◽

2019 ◽

Author(s):

KZ Thein ◽

S Swarup ◽

A Sultan ◽

L Tijani ◽

N D'Cunha ◽

...

Keyword(s):

Breast Cancer ◽

Interstitial Lung Disease ◽

Advanced Breast Cancer ◽

Lung Disease ◽

Controlled Trials ◽

Her2 Positive ◽

Phase 3 ◽

Two Phase ◽

Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials

Pediatric Dermatology ◽

10.1111/pde.13723 ◽

2018 ◽

Vol 36 (1) ◽

pp. 89-99 ◽

Cited By ~ 10

Author(s):

Adelaide A. Hebert ◽

Dee Anna Glaser ◽

Lawrence Green ◽

William P. Werschler ◽

Douglass W. Forsha ◽

...

Keyword(s):

Controlled Trials ◽

Efficacy And Safety ◽

Axillary Hyperhidrosis ◽

Two Phase ◽

Post Hoc Analysis ◽

Randomized Controlled ◽

Post Hoc

Safety and efficacy of gefapixant, a novel drug for the treatment of chronic cough: A systematic review and meta-analysis of randomized controlled trials

Annals of Thoracic Medicine ◽

10.4103/atm.atm_417_20 ◽

2021 ◽

Vol 16 (2) ◽

pp. 127

Author(s):

Ahmed Abu-Zaid ◽

AseelKhalid Aljaili ◽

Amnah Althaqib ◽

Fatima Adem ◽

DoaaAli Alhalal ◽

...

Keyword(s):

Systematic Review ◽

Chronic Cough ◽

Meta Analysis ◽

Controlled Trials ◽

Safety And Efficacy ◽

Randomized Controlled ◽

Novel Drug

Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials

Pediatric Dermatology ◽

10.1111/pde.13877 ◽

2019 ◽

Vol 36 (3) ◽

pp. 424-424

Keyword(s):

Controlled Trials ◽

Efficacy And Safety ◽

Axillary Hyperhidrosis ◽

Two Phase ◽

Post Hoc Analysis ◽

Randomized Controlled ◽

Post Hoc